Brief: Synact Pharma Draws SEK 50 Mln Under Facility Via Convertible Loans
20/07/2026 09:57
BRIEF-Synact Pharma Draws SEK 50 Mln Under Facility Via Convertible Loans July 20 (Reuters) - SynAct Pharma AB SYNACT.ST:
DRAWS SEK 50 MILLION UNDER FACILITY VIA CONVERTIBLE LOANS
TERMINATES PREVIOUS CREDIT FACILITY WITH HUNTER CAPITAL
Source text: ID:nMFN6V4qZK
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development